Recombinant DNA vaccines: rationale and strategy
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York u.a.
Dekker
1992
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XIV, 409 S. Ill., graph. Darst. |
ISBN: | 0824786998 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV006321035 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 930222s1992 ad|| |||| 00||| engod | ||
020 | |a 0824786998 |9 0-8247-8699-8 | ||
035 | |a (OCoLC)25964640 | ||
035 | |a (DE-599)BVBBV006321035 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-355 |a DE-11 | ||
050 | 0 | |a QR189.2 | |
082 | 0 | |a 615/.372 |2 20 | |
084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
245 | 1 | 0 | |a Recombinant DNA vaccines |b rationale and strategy |c ed. by Richard E. Isaacson |
264 | 1 | |a New York u.a. |b Dekker |c 1992 | |
300 | |a XIV, 409 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a ADN recombinant | |
650 | 4 | |a Vaccins synthétiques | |
650 | 4 | |a DNA, Recombinant | |
650 | 4 | |a Recombinant DNA | |
650 | 4 | |a Synthetic vaccines | |
650 | 4 | |a Vaccines, Synthetic | |
650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Rekombinante DNS |0 (DE-588)4225578-8 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Rekombinante DNS |0 (DE-588)4225578-8 |D s |
689 | 0 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Isaacson, Richard E. |e Sonstige |4 oth | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003999168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-003999168 |
Datensatz im Suchindex
_version_ | 1804120538232127488 |
---|---|
adam_text | RECOMBINANT DNA VACCINES RATIONALE AND STRATEGY EDITED BY RICHARD E.
ISAACSON UNIVERSITY OF ILLINOIS URBANA, ILLINOIS MARCEL DEKKER, INC. NEW
YORK * BASEL * HONG KONG CONTENTS PREFACE III CONTRIBUTORS VII
INTRODUCTION (GARY K. SCHOOLNIK) XI PART ONE RATIONALE 1. THE RATIONALE
FOR RDNA VACCINES 1 RICHARD E. ISAACSON 2. MODERN APPROACHES TO THE
DEVELOPMENT OF ATTENUATED VIRUS STRAINS 19 ANNE FLAMAND 3. DEVELOPMENT
OF NONTOXIC IMMUNOGENIC ANALOGS OF TOXINS FOR VACCINES WITH EMPHASIS ON
PERTUSSIS TOXIN 49 JAMES L. COWELL, ROBERT A. DEICH, AND ALAN KIMURA 4.
BACTERIAL VIRULENCE AS STRATEGIES TO DEVELOP VACCINES 73 STEVEN CLEGG VI
CONTENTS 5. PHASE AND ANTIGENIC VARIATION OF BACTERIAL COLONIZATION
FACTORS IN THE DEVELOPMENT OF RECOMBINANT VACCINES 89 BARRY I.
EISENSTEIN, J. MICHAEL KOOMEY, AND PER KLEMM 6. ANTIGENIC VARIATION IN
PARASITIC PROTOZOA 115 C. M. R. TURNER 7. STRATEGIES TO ACHIEVE MUCOSAL
IMMUNITY 147 DAVID F. KEREN AND LAWRENCE K. SILBART PART TWO STRATEGY 8.
CLONING STRATEGIES IN PROKARYOTES 169 JOHN F. BARRETT AND RICHARD E.
ISAACSON 9. THE UTILITY OF FUSION PROTEINS IN THE DEVELOPMENT OF
VACCINES 199 EGON AMANN 10. VACCINIA VIRUS AS A CLONING AND DELIVERY
SYSTEM FOR VACCINES 223 MICHAEL MACKETT 11. BACULOVIRUS EXPRESSION
VECTORS 265 DONALD L. JARVIS AND MAX D. SUMMERS 12. USE OF ATTENUATED
BACTERIA AS LIVE ORAL VACCINE VECTORS 293 JOHN D. CLEMENTS, JIAN XIONG
BAO, AND LUCIA CARDENAS 13. MINICELLS AS SPECIALIZED VACCINES AND
VACCINE CARRIERS 323 GEORGE G. KHACHATOURIANS 14. RATIONALE FOR THE
DESIGN OF ANTI-IDIOTYPIC ANTIBODY VACCINES 335 SYBILLE MULLER, HEINZ
KB HLER, AND DARRELL ANDERSON 15. THE ISCOM*AN APPROACH TO SUBUNIT
VACCINES 369 BROR MOREIN AND LENNART AKERBLOM 16. SAFETY OF RECOMBINANT
VACCINES 387 EDWIN C. HAHN INDEX 401
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV006321035 |
callnumber-first | Q - Science |
callnumber-label | QR189 |
callnumber-raw | QR189.2 |
callnumber-search | QR189.2 |
callnumber-sort | QR 3189.2 |
callnumber-subject | QR - Microbiology |
classification_rvk | XD 3300 |
ctrlnum | (OCoLC)25964640 (DE-599)BVBBV006321035 |
dewey-full | 615/.372 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.372 |
dewey-search | 615/.372 |
dewey-sort | 3615 3372 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01625nam a2200445 c 4500</leader><controlfield tag="001">BV006321035</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930222s1992 ad|| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824786998</subfield><subfield code="9">0-8247-8699-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)25964640</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006321035</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR189.2</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.372</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Recombinant DNA vaccines</subfield><subfield code="b">rationale and strategy</subfield><subfield code="c">ed. by Richard E. Isaacson</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York u.a.</subfield><subfield code="b">Dekker</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 409 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ADN recombinant</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccins synthétiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA, Recombinant</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recombinant DNA</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Synthetic vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines, Synthetic</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rekombinante DNS</subfield><subfield code="0">(DE-588)4225578-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Rekombinante DNS</subfield><subfield code="0">(DE-588)4225578-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Isaacson, Richard E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003999168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003999168</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV006321035 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:43:40Z |
institution | BVB |
isbn | 0824786998 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003999168 |
oclc_num | 25964640 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR DE-11 |
owner_facet | DE-12 DE-355 DE-BY-UBR DE-11 |
physical | XIV, 409 S. Ill., graph. Darst. |
publishDate | 1992 |
publishDateSearch | 1992 |
publishDateSort | 1992 |
publisher | Dekker |
record_format | marc |
spelling | Recombinant DNA vaccines rationale and strategy ed. by Richard E. Isaacson New York u.a. Dekker 1992 XIV, 409 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier ADN recombinant Vaccins synthétiques DNA, Recombinant Recombinant DNA Synthetic vaccines Vaccines, Synthetic Impfstoff (DE-588)4026655-2 gnd rswk-swf Rekombinante DNS (DE-588)4225578-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Rekombinante DNS (DE-588)4225578-8 s Impfstoff (DE-588)4026655-2 s DE-604 Isaacson, Richard E. Sonstige oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003999168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Recombinant DNA vaccines rationale and strategy ADN recombinant Vaccins synthétiques DNA, Recombinant Recombinant DNA Synthetic vaccines Vaccines, Synthetic Impfstoff (DE-588)4026655-2 gnd Rekombinante DNS (DE-588)4225578-8 gnd |
subject_GND | (DE-588)4026655-2 (DE-588)4225578-8 (DE-588)4143413-4 |
title | Recombinant DNA vaccines rationale and strategy |
title_auth | Recombinant DNA vaccines rationale and strategy |
title_exact_search | Recombinant DNA vaccines rationale and strategy |
title_full | Recombinant DNA vaccines rationale and strategy ed. by Richard E. Isaacson |
title_fullStr | Recombinant DNA vaccines rationale and strategy ed. by Richard E. Isaacson |
title_full_unstemmed | Recombinant DNA vaccines rationale and strategy ed. by Richard E. Isaacson |
title_short | Recombinant DNA vaccines |
title_sort | recombinant dna vaccines rationale and strategy |
title_sub | rationale and strategy |
topic | ADN recombinant Vaccins synthétiques DNA, Recombinant Recombinant DNA Synthetic vaccines Vaccines, Synthetic Impfstoff (DE-588)4026655-2 gnd Rekombinante DNS (DE-588)4225578-8 gnd |
topic_facet | ADN recombinant Vaccins synthétiques DNA, Recombinant Recombinant DNA Synthetic vaccines Vaccines, Synthetic Impfstoff Rekombinante DNS Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003999168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT isaacsonricharde recombinantdnavaccinesrationaleandstrategy |